Metformin alters H2A.Z dynamics and regulates androgen dependent prostate cancer progression.

Tyagi M, Cheema MS, Dryhurst D, Eskiw CH, Ausió J

Open source

DOI
10.18632/oncotarget.26457
Published
2018 Dec 11
Container
Oncotarget
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.26457,
  title = {Metformin alters H2A.Z dynamics and regulates androgen dependent prostate cancer progression.},
  author = {Tyagi M and Cheema MS and Dryhurst D and Eskiw CH and Ausió J},
  year = {2018},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.26457},
  url = {https://doi.org/10.18632/oncotarget.26457}
}

RIS

TY  - JOUR
TI  - Metformin alters H2A.Z dynamics and regulates androgen dependent prostate cancer progression.
AU  - Tyagi M
AU  - Cheema MS
AU  - Dryhurst D
AU  - Eskiw CH
AU  - Ausió J
PY  - 2018
JO  - Oncotarget
DO  - 10.18632/oncotarget.26457
UR  - https://doi.org/10.18632/oncotarget.26457
ER  - 

APA

M, T., MS, C., D, D., CH, E., & J, A. (2018). Metformin alters H2A.Z dynamics and regulates androgen dependent prostate cancer progression.. Oncotarget. https://doi.org/10.18632/oncotarget.26457

Source records